Patents by Inventor Evan Abrahamse
Evan Abrahamse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230380438Abstract: The invention concerns a native whey protein composition with profound amounts of native whey protein and with beta-casein for use in the treatment and/or prevention of gastrointestinal intolerance. The inventors found that the native whey protein composition relatively high in beta-casein and low in kappa- and alpha-casein provides a beneficial effect on gastrointestinal intolerance.Type: ApplicationFiled: October 27, 2021Publication date: November 30, 2023Applicant: N.V. NutriciaInventors: Ingrid Brunhilde Renes, Evan Abrahamse, Gerrit Hols
-
Patent number: 11490631Abstract: An infant formula for preventing gastro-esophageal reflux is disclosed comprising whey protein and/or casein, a galactomannan thickener, and a fermented milk-derived product.Type: GrantFiled: March 18, 2020Date of Patent: November 8, 2022Assignee: N.V. NUTRICIAInventors: Marie Thomas, Francis Lecroix, Evan Abrahamse, Houkje Bouritius
-
Publication number: 20220016204Abstract: The invention concerns native whey protein for use in (a) improving intestinal maturation; and/or (b) reducing and/or preventing intestinal permeability. The inventors found that native whey protein provides a beneficial effect on intestinal maturation and permeability.Type: ApplicationFiled: February 3, 2020Publication date: January 20, 2022Applicant: N.V. NutriciaInventors: Ingrid Brunhilde Renes, Rudolph Eduardus Maria Verdurmen, Gerrit Hols, Evan Abrahamse
-
Publication number: 20210401894Abstract: The invention concerns native whey protein for use in the treatment and/or prevention of intestinal infection or inflammation, in particular necrotizing enterocolitis. The inventors found that native whey protein provides a beneficial effect on intestinal infection or inflammation.Type: ApplicationFiled: February 3, 2020Publication date: December 30, 2021Applicant: N.V. NutriciaInventors: Ingrid Brunhilde Renes, Rudolph Eduardus Maria Verdurmen, Gerrit Hols, Evan Abrahamse
-
Patent number: 11116233Abstract: The invention pertains to a process for simultaneous producing an infant formula product and an acidic dairy product from defatted animal milk, comprising (a) processing the milk into a casein stream, a whey protein stream and a lactose stream, by: (i) subjecting the defatted animal milk to a filtration step over a microfiltration membrane capable of retaining bacteria and permeating milk proteins, to provide a debacterialized milk as permeate; (ii) subjecting the permeate originating from step (i) to a filtration step over a microfiltration membrane capable of retaining casein and permeating whey proteins, to provide a casein stream as retentate and a permeate comprising whey protein; (iii) fractionating the permeate originating from step (ii) into a whey protein stream and a lactose stream; (b) combining part of the casein stream, at least part of the whey protein stream originating from step (a) and a lactose source to obtain a recombined stream, wherein the lactose source comprises acid whey; (c) using thType: GrantFiled: August 8, 2017Date of Patent: September 14, 2021Assignees: Compagnie Gervais Danone, N.V. NutriciaInventors: Franck David, Claire Queguiner, Laurent Schmitt, Gerrit Hols, John Tobin, Raoul Charles Johan Moonen, Evelien Louise Van Eijk-Van Boxtel, Evan Abrahamse
-
Patent number: 10602752Abstract: An infant formula for preventing gastro-esophageal reflux is disclosed comprising whey protein and/or casein, a galactomannan thickener, and a fermented milk-derived product.Type: GrantFiled: April 15, 2010Date of Patent: March 31, 2020Assignee: N.V. NUTRICIAInventors: Marie Thomas, Francis Lecroix, Evan Abrahamse, Houkje Bouritius
-
Patent number: 9717270Abstract: The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation.Type: GrantFiled: February 24, 2017Date of Patent: August 1, 2017Assignee: N.V. NutriciaInventors: Thomas Ludwig, Sylvie Huybers, Evan Abrahamse, Houkje Bouritius
-
Patent number: 9617327Abstract: The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation.Type: GrantFiled: June 14, 2013Date of Patent: April 11, 2017Assignee: N.V. NutriciaInventors: Thomas Ludwig, Sylvie Huybers, Evan Abrahamse, Houkje Bouritius
-
Patent number: 9307780Abstract: A sterilized food product containing starch, the starch having: (a) an amylose content of at least 60 wt. %; (b) a median particle size of between 1 and 15 ?m, at least 90 wt. % of the starch particles having a particle diameter of less than 50 ?m; and (c) a non-digestible starch content of less than 50 wt. %. The product is obtained by heating and rapidly cooling the starch product and has a high slowly digestible starch content. It is suitable for use in the treatment of diabetes, obesity, insulin resistance, or for postprandial glucose response.Type: GrantFiled: January 7, 2014Date of Patent: April 12, 2016Assignee: N.V. NUTRICIAInventors: Evan Abrahamse, Wynette Hermina Agnes Kiers, Houkje Bouritius, Koenraad Gerard Christoffel Weel
-
Patent number: 9247763Abstract: The invention relates to a combination of heat-treated nutritional composition having a carbohydrate fraction comprising a) 5-30 wt % of one or more monosaccharides selected from galactose, ribose and mannose; b) carbohydrates capable of providing b1) sustained release glucose and b2) rapidly available glucose; c) optionally fructose; d) glucose-containing disaccharides other than maltose and sucrose; and e) optionally sugar polyols. The invention also pertains to the use of such a heat-treated nutritional composition for controlling glucose levels in blood and/or tissue, especially for preventing and/or treating diabetics, insulin-resistance, obesity, postprandial glucose response, metabolic syndrome, syndrome X, hyperglycemia, hypertriglyceridemia, hyperinsulinemia, dyslipidemia, dysfibrinolysis and/or disorders associated with major surgery or trauma.Type: GrantFiled: July 5, 2006Date of Patent: February 2, 2016Assignee: N.V. NutriciaInventors: Houkje Bouritius, Evan Abrahamse, Wynette Hermina Agnes Kiers, Chantal Severijnen, Katrien Maria Jozefa van Laere, Robert Johan Joseph Hageman
-
Publication number: 20150132365Abstract: The present invention relates to a fermented infant formulae comprising non digestible oligosaccharides for improving intestinal tract health by decreasing protein digestive effort, by decreasing the amount of endogenously formed proteases concomitant with an increased protein digestion, and a reduced protein fermentation.Type: ApplicationFiled: June 14, 2013Publication date: May 14, 2015Applicant: N.V. NutriciaInventors: Thomas Ludwig, Sylvie Huybers, Evan Abrahamse, Houkje Bouritius
-
Patent number: 8642110Abstract: A sterilized food product containing starch, the starch having: (a) an amylose content of at least 60 wt. %; (b) a median particle size of between 1 and 15 &mgr; m, at least 90 wt. % of the starch particles having a particle diameter of less than 50 &mgr; m; and (c) a non-digestible starch content of less than 50 wt. %; and (d) a slowly digestible starch content of 15-75 wt. %. The product is obtained by heating and rapidly cooling the starch product and has a high slowly digestible starch content. It is suitable for use in the treatment of diabetes, obesitas, insulin resistance, or for postprandial glucose response.Type: GrantFiled: December 28, 2007Date of Patent: February 4, 2014Assignee: N.V. NutriciaInventors: Evan Abrahamse, Wynette Hermina Agnes Kiers, Houkje Bouritius, Koenraad Gerard Christoffel Weel
-
Publication number: 20130337105Abstract: The present invention relates to a fermented infant formulae for decreasing protein digestive effort by decreasing the amount of endogenously formed proteases, concomitant with an increased protein digestion. The invention also relates to low protein fermented infant formulae.Type: ApplicationFiled: December 5, 2011Publication date: December 19, 2013Inventors: Thomas Ludwig, Sylvie Huybers, Evan Abrahamse, Houkje Bouritius
-
Publication number: 20120213858Abstract: An infant formula for preventing gastro-esophageal reflux is disclosed comprising whey protein and/or casein, a galactomannan thickener, and a fermented milk-derived product.Type: ApplicationFiled: April 15, 2010Publication date: August 23, 2012Inventors: Marie Thomas, Francis Lecroix, Evan Abrahamse, Houkje Bouritius
-
Publication number: 20100086668Abstract: A sterilised food product containing starch, the starch having: (a) an amylose content of at least 60 wt. %; (b) a median particle size of between 1 and 15 &mgr;m, at least 90 wt. % of the starch particles having a particle diameter of less than 50 &mgr;m; and (c) a non-digestible starch content of less than 50 wt. %; and (d) a slowly digestible starch content of 15-75 wt. %. The product is obtained by heating and rapidly cooling the starch product and has a high slowly digestible starch content. It is suitable for use in the treatment of diabetes, obesitas, insulin resistance, or for postprandial glucose response.Type: ApplicationFiled: December 28, 2007Publication date: April 8, 2010Applicant: N.V. NUTRICIAInventors: Evan Abrahamse, Wynette Hermina Agnes Kiers, Houkje Bouritius, Koenraad Gerard Christoffel Weel
-
Publication number: 20090011990Abstract: The invention relates to a combination of heat-treated nutritional composition having a carbohydrate fraction comprising a) 5-30 wt % of one or more monosaccharides selected from galactose, ribose and mannose; b) carbohydrates capable of providing b1) sustained release glucose and b2) rapidly available glucose; c) optionally fructose; d) glucose-containing disaccharides other than maltose and sucrose; and e) optionally sugar polyols. The invention also pertains to the use of such a heat-treated nutritional composition for controlling glucose levels in blood and/or tissue, especially for preventing and/or treating diabetics, insulin-resistance, obesity, postprandial glucose response, metabolic syndrome, syndrome X, hyperglycemia, hypertriglyceridemia, hyperinsulinemia, dyslipidemia, dysfibrinolysis and/or disorders associated with major surgery or trauma.Type: ApplicationFiled: July 5, 2006Publication date: January 8, 2009Inventors: Houkje Bouritius, Evan Abrahamse, Wynette Hermina Kiers, Chantal Severijnen, Katrien Maria Jozefa van Laere, Robert Johan Hageman